亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Efficacy and Safety of Tacrolimus in the Treatment of Pediatric Henoch–Schönlein Purpura Nephritis

医学 他克莫司 环磷酰胺 胃肠病学 蛋白尿 肾功能 内科学 不利影响 泌尿系统 泌尿科 化疗 移植
作者
Dengyan Wu,Rui Ma,Xingmin Wang,Yonghong Yang
出处
期刊:Pediatric Drugs [Adis, Springer Healthcare]
卷期号:24 (4): 389-401 被引量:3
标识
DOI:10.1007/s40272-022-00506-1
摘要

Children with severe Henoch-Schönlein purpura nephritis (HSPN) may progress to end-stage renal disease without appropriate treatment.This study aimed to investigate the efficacy and safety of tacrolimus combined with glucocorticoids in the treatment of pediatric HSPN.A total of 87 HSPN patients with urinary protein ≥ 0.75 g/24 h received standard of care, including angiotensin II receptor blockers/angiotensin-converting enzyme inhibitors and glucocorticoids. Patients were divided into three groups and additionally received tacrolimus (n = 30), cyclophosphamide (n = 31), or mycophenolate mofetil (MMF) (n = 26). We monitored outcome measures, including proteinuria, hematuria, and renal function and analyzed the efficacy and side effects in each group.At 2-month follow-up, the overall efficacy was 93.3%, 83.9%, and 61.5% for tacrolimus, cyclophosphamide, and MMF, respectively (P < 0.05). Urinary protein significantly decreased for all groups. Urinary red blood cell counts significantly decreased for patients treated with tacrolimus (P < 0.001) and cyclophosphamide (P < 0.05), whereas no significant decrease was seen for those receiving MMF (P = 0.09). Although urine β2-microglobulin significantly decreased following 2 months of treatment with all medications, efficacy was greater with tacrolimus than with cyclophosphamide and MMF (P < 0.001). Major adverse events were respiratory and urinary infections, with MMF having the highest infection rate. The cyclophosphamide group also experienced additional adverse events, including arrhythmia, hemorrhagic cystitis, leukocytosis, thrombocytopenia, and hyperglycemia.These results indicate that tacrolimus is more effective at reducing proteinuria and hematuria and improving renal function, with relatively milder side effects, in the treatment of pediatric HSPN.ChiCTR2200055323, retrospectively registered on January 7, 2022.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ColinWine完成签到 ,获得积分10
8秒前
小彤完成签到 ,获得积分10
11秒前
量子星尘发布了新的文献求助10
23秒前
orixero应助ceeray23采纳,获得20
24秒前
blenx完成签到,获得积分10
36秒前
英姑应助科研通管家采纳,获得10
41秒前
传奇3应助科研通管家采纳,获得10
41秒前
44秒前
ceeray23发布了新的文献求助20
49秒前
CNY完成签到 ,获得积分10
52秒前
赘婿应助无私的香菇采纳,获得10
54秒前
健壮的花瓣完成签到 ,获得积分10
55秒前
称心的海蓝完成签到,获得积分10
57秒前
1分钟前
ceeray23发布了新的文献求助20
1分钟前
酷酷幻灵完成签到 ,获得积分10
1分钟前
恻隐发布了新的文献求助10
1分钟前
星辰大海应助正直雍采纳,获得10
1分钟前
1分钟前
1分钟前
Hello应助恻隐采纳,获得10
1分钟前
正直雍发布了新的文献求助10
1分钟前
量子星尘发布了新的文献求助10
1分钟前
kd1412应助正直雍采纳,获得30
1分钟前
2分钟前
2分钟前
哈哈发布了新的文献求助30
2分钟前
2分钟前
2分钟前
田様应助哈哈采纳,获得30
2分钟前
yyy完成签到 ,获得积分10
2分钟前
3分钟前
隐形萃发布了新的文献求助10
3分钟前
mellow完成签到,获得积分10
3分钟前
3分钟前
慕青应助隐形萃采纳,获得10
3分钟前
整齐乐荷发布了新的文献求助10
3分钟前
量子星尘发布了新的文献求助10
3分钟前
KK完成签到,获得积分10
3分钟前
3分钟前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 1000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 310
宽量程高线性度柔性压力传感器的逆向设计 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3980868
求助须知:如何正确求助?哪些是违规求助? 3524642
关于积分的说明 11222242
捐赠科研通 3262101
什么是DOI,文献DOI怎么找? 1801072
邀请新用户注册赠送积分活动 879591
科研通“疑难数据库(出版商)”最低求助积分说明 807429